These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4151868)

  • 1. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R; Walker JG; West B; Hill MJ
    Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    West B; Lendrum R; Hill MJ; Walker G
    Gut; 1974 Dec; 15(12):960-5. PubMed ID: 4155692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of fecal flora and its correlation with inflammatory indicators in patients with inflammatory bowel disease].
    Zhang T; Chen Y; Wang Z; Zhou Y; Zhang S; Wang P; Xie S; Jiang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1474-7. PubMed ID: 24144750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile and inflammatory bowel disease.
    Greenfield C; Aguilar Ramirez JR; Pounder RE; Williams T; Danvers M; Marper SR; Noone P
    Gut; 1983 Aug; 24(8):713-7. PubMed ID: 6135648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.
    Gorbach SL; Nahas L; Plaut AG; Weinstein L; Patterson JF; Levitan R
    Gastroenterology; 1968 Apr; 54(4):575-87. PubMed ID: 4385122
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence of Clostridium difficile toxin in inflammatory bowel disease.
    Rolny P; Järnerot G; Möllby R
    Scand J Gastroenterol; 1983 Jan; 18(1):61-4. PubMed ID: 6144171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.
    Cooke EM
    Gut; 1969 Jul; 10(7):565-8. PubMed ID: 4390007
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT
    N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
    [No Abstract]   [Full Text] [Related]  

  • 9. A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons.
    Cooke EM
    J Pathol Bacteriol; 1967 Oct; 94(2):439-44. PubMed ID: 4965244
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulfasalazine therapy in inflammatory bowel disease.
    Das KM
    Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial L-form isolation from inflammatory bowel disease patients.
    Belsheim MR; Darwish RZ; Watson WC; Schieven B
    Gastroenterology; 1983 Aug; 85(2):364-9. PubMed ID: 6134652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible mechanism of action of Azulfidine/Salazopyrin].
    Campbell DE
    Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammatory bowel disease. Part II.
    Hansen R
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mode of action of sulfasalazine in chronic inflammatory enterocolonic diseases].
    Delboy H
    Therapie; 1992; 47(2):157-9. PubMed ID: 1357770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Azulfidine/Salazopyrin therapy during pregnancy].
    Fahrländer H
    Z Gastroenterol Verh; 1981 Jun; 19():24-6. PubMed ID: 6168128
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (salazopyrin).
    Dissanayake AS; Truelove SC
    Gut; 1973 Oct; 14(10):818. PubMed ID: 4148469
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy of inflammatory bowel disease.
    Gardner RC
    J Maine Med Assoc; 1976 Jul; 67(7):206-14. PubMed ID: 9461
    [No Abstract]   [Full Text] [Related]  

  • 19. Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
    Kolho KL; Korpela K; Jaakkola T; Pichai MV; Zoetendal EG; Salonen A; de Vos WM
    Am J Gastroenterol; 2015 Jun; 110(6):921-30. PubMed ID: 25986361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H; Kruis W
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.